Effectiveness Study of Hylan G-F 20 to Preserve Cartilage in Osteoarthritis of the Knee

• Status: Unknown status
• Trial end date: 2006-01-01
• Target enrollment: 0
• Participant gender: All

Summary

That Hylan G-F 20 may act to protect cartilage from the expected degree of degradation over a 12 month period in subjects with moderate to marked osteoarthritis of the knee

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cabrini Medical Centre
• Collaborator: Genzyme, a Sanofi Company
• Treatments: Hyaluronic Acid; Hylan

Criteria

Inclusion Criteria:

• grade 2 or 3 osteoarthritis knee age 18 - 80 pain score VAS >39 mm on 100mm scale

Exclusion Criteria:

• surgery in prior 12 months significant valgus deformity recent trauma use of opioid analgesia unstable medical condition recent corticosteroid injection morbid obesity